Proteomics-based Predictive Model for the Early Detection of Metastasis and Recurrence in Head and Neck Cancer
Open Access
- 28 April 2020
- journal article
- research article
- Published by International Institute of Anticancer Research in Cancer Genomics & Proteomics
- Vol. 17 (3) , 259-269
Abstract
Background/Aim: Head and neck squamous cell carcinoma (HNSCC) presents high morbidity, an overall poor prognosis and survival, and a compromised quality of life of the survivors. Early tumor detection, prediction of its behavior and prognosis as well as the development of novel therapeutic strategies are urgently needed for a more successful HNSCC management. Materials and Methods: In this study, a proteomics analysis of HNSCC tumor and non-tumor samples was performed and a model to predict the risk of recurrence and metastasis development was built. Results: This predictive model presented good accuracy (>80%) and comprises as variables the tumor staging along with DHB12, HMGB3 and COBA1 proteins. Differences at the intensity levels of these proteins were correlated with the development of metastasis and recurrence as well as with patient's survival. Conclusion: The translation of proteomic predictive models to routine clinical practice may contribute to a more precise and individualized clinical management of the HNSCC patients, reducing recurrences and improving patients' quality of life. The capability of generalization of this proteomic model to predict the recurrence and metastases development should be evaluated and validated in other HNSCC populations.Keywords
This publication has 38 references indexed in Scilit:
- Neuroproteomics Using Short GeLC-SWATH: From the Evaluation of Proteome Changes to the Clarification of Protein Function2017
- SWATH‐MS as a tool for biomarker discovery: From basic research to clinical applicationsProteomics, 2017
- WT1, MSH6, GATA5 and PAX5 as epigenetic oral squamous cell carcinoma biomarkers - a short reportCellular Oncology, 2016
- Overexpression of HMGB3 protein promotes cell proliferation, migration and is associated with poor prognosis in urinary bladder cancer patientsTumor Biology, 2015
- Short GeLC‐SWATH: A fast and reliable quantitative approach for proteomic screeningsProteomics, 2014
- Genetic gains and losses in oral squamous cell carcinoma: impact on clinical managementCellular Oncology, 2013
- Mass spectrometry‐based clinical proteomics: Head‐and‐neck cancer biomarkers and drug‐targets discoveryMass Spectrometry Reviews, 2010
- HMGB proteins: Interactions with DNA and chromatinBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2010
- Molecular Profiling and the Identification of Genes Associated With Metastatic Oral Cavity/Pharynx Squamous Cell CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 2004
- Markers for Assessment of Nodal Metastasis in Laryngeal CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 1997